(Q53626155)

16 May 2018

title

Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma. (English)

1 reference

16 May 2018

0 references

5

1 reference

16 May 2018

Ayalew Tefferi

11

Tefferi A

1 reference

16 May 2018

10

Litzow MR

1 reference

16 May 2018

Morie A Gertz

8

Gertz MA

1 reference

16 May 2018

Martha Q Lacy

9

Lacy MQ

1 reference

16 May 2018

Francis K Buadi

1

Buadi FK

1 reference

16 May 2018

author name string

Micallef IN

2

1 reference

16 May 2018

Ansell SM

3

1 reference

16 May 2018

Porrata LF

4

1 reference

16 May 2018

Elliot MA

6

1 reference

16 May 2018

Gastineau DA

7

1 reference

16 May 2018

Inwards DJ

12

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 June 2006

1 reference

16 May 2018

Bone Marrow Transplantation

published in

1 reference

16 May 2018

volume

37

1 reference

16 May 2018

issue

11

1 reference

16 May 2018

page(s)

1017-1022

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705371

exact match

0 references

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Non-Hodgkin's lymphoma in the elderly. I. Pathologic features at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Variation in lymphoma incidence within Yorkshire Health Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Autologous blood and marrow transplantation in patients 60 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

Treatment of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

7 January 2021

Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

7 January 2021

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

7 January 2021

Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

7 January 2021

Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705371

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705371

1 reference

16 May 2018

PubMed ID

16633361

1 reference

16 May 2018